Synopsis of recent research by authors named "Nahoko Furuya"
- Nahoko Furuya's research primarily focuses on the treatment and management of various hematological malignancies, with notable studies on tyrosine kinase inhibitors, allogeneic stem cell transplantation, and the impact of viral infections in patients undergoing treatment for blood cancers
- Recent findings include the exploration of ovarian hyperstimulation syndrome in a patient undergoing controlled ovarian stimulation after leukemia induction therapy, and the influence of gilteritinib on dominant clone selection in acute myeloid leukemia patients during long-term treatment
- Furuya's investigations have also highlighted the challenges of immunosuppression-related complications, such as post-transplant lymphoproliferative disease, and the utility of innovative imaging techniques like diffusion-weighted imaging for assessing treatment response in plasma-cell neoplasms